Basket Combination Study of Inhibitors of DNA Damage Response, Angiogenesis and Programmed Death Ligand 1 in Patients With Advanced Solid Tumors
Learn more about:
Related Clinical Trial
Exploring Clinical Trial Experiences of People With Leiomyosarcoma
Circulating ” Cancer Cells / Macrophage ” HYbrid Cells in Patients With Sarcoma, Part 2
A Study of Unesbulin in Participants With Advanced Leiomyosarcoma (LMS)
Temozolomide for Injection Combined With Epirubicin in First-line Treatment of Leiomyosarcoma
Targeting ATR in Soft-tissue Sarcomas
CytoreductiveSurgery & HIPEC w/Gemcitabine+Chemotherapy w/Dacarbazine in Uterine Leiomyosarcoma
A Study of Rucaparib and Nivolumab in People With Leiomyosarcoma
Metronomic Trabectedin, Gemcitabine, and Dacarbazine for Leiomyosarcoma
S9624 Ifosfamide in Treating Patients With Meningeal Tumors
A Phase 1/2 Study of CYT-0851, an Oral RAD51 Inhibitor, in B-Cell Malignancies and Advanced Solid Tumors
Gemcitabine and Docetaxel With Bevacizumab in Selected Sarcoma Subtypes
Cytotoxic T Cells to Treat Relapsed EBV-positive Lymphoma
Basket Combination Study of Inhibitors of DNA Damage Response, Angiogenesis and Programmed Death Ligand 1 in Patients With Advanced Solid Tumors
LMP-specific T-cells for Patients With Relapsed EBV-positive Lymphoma
Concordance Between Gynaecologic Sonography Amd Pelvic MRI for the Pre-surgical Diagnosis of Uterine Mesenchimal Malignant Tumors
A Study of PTC596 in Combination With Dacarbazine in Participants With Advanced Leiomyosarcoma (LMS)
Efficacy of Gemcitabine With Pazopanib as Second Line Treatment in Patient With Metastatic or Relapsed Uterine
Adjuvant Chemotherapy for High Risk Uterine Leiomyosarcoma
Letrozole Versus Observation in Patients With Newly Diagnosed Uterine Leiomyosarcoma
Letrozole in Women With Advanced Estrogen/Progesterone Receptor Positive Uterine Leiomyosarcoma
Development of a Predictive Model for Early Differential Diagnosis of Uterine Leiomyomas and Leiomyosarcomas
Trabectedin, Doxorubicin and Olaratumab in Patients With Metastatic or Recurrent Leiomyosarcoma